PharmiWeb.com - Global Pharma News & Resources

Healthcare - Articles

Discover the causes, symptoms, and effective treatment options for low platelet count. Learn how to manage platelet deficiency naturally through diet, lifestyle changes, and medical care.
A low platelet count, also known as thrombocytopenia, is a medical condition where the blood has an abnormally low number of platelets, cells responsible for helping the blood clot. A normal platelet count ranges from 150,000 to 450,000 platelets per microliter of blood. When this count drops below the normal range, it can lead to excessive bleeding, easy bruising, and delayed wound healing. Fortunately, with the right low platelet count medication, managing thrombocytopenia is possible. In this blog, we will explore the causes, symptoms, and most importantly, the medications available for treating…
G-Protein Coupled Receptors  Market (GPCRs) represent a large and diverse group of membrane proteins involved in transmitting a variety of signals from outside the cell into the cell’s interior. These receptors play a pivotal role in numerous physiological processes and are implicated in various disease states, making them a prominent target for therapeutic drug development.
G-Protein Coupled Receptors (GPCR) Market Report Introduction G-Protein Coupled Receptors  Market (GPCRs) represent a large and diverse group of membrane proteins involved in transmitting a variety of signals from outside the cell into the cell’s interior. These receptors play a pivotal role in numerous physiological processes and are implicated in various disease states, making them a prominent target for the…
The Interventional Oncology Market is witnessing a dynamic shift as advanced, image-guided, minimally invasive therapies increasingly become a preferred treatment option for cancer patients. Valued at USD 3.9 billion in 2025, the global market is expanding at a compound annual growth rate (CAGR) of 7.2% over the forecast period.
The Interventional Oncology Market is witnessing a dynamic shift as advanced, image-guided, minimally invasive therapies increasingly become a preferred treatment option for cancer patients. Valued at USD 3.9 billion in 2025, the global market is expanding at a compound annual growth rate (CAGR) of 7.2% over the forecast period. This growth is fueled by technological innovations, rising cancer incidence, and a global focus on less invasive treatment modalities that…
Flexible spinal implants represent a significant advancement in spinal surgery and orthopedic healthcare. Designed to offer improved flexibility, reduced stress shielding, and more physiological motion preservation compared to traditional rigid spinal devices
Flexible Spinal Implants Market Report Introduction Flexible spinal implants represent a significant advancement in spinal surgery and orthopedic healthcare. Designed to offer improved flexibility, reduced stress shielding, and more physiological motion preservation compared to traditional rigid spinal devices, these implants are used in the treatment of various spinal disorders including degenerative disc disease, scoliosis, and spinal stenosis. The market is evolving with innovations aimed at improving patient outcomes, minimizing in…
Artificial Intelligence (AI) is no longer a futuristic concept in the pharmaceutical industry — it is today’s reality, revolutionizing how drugs are discovered, designed, and developed. The integration of AI into drug discovery is dramatically reshaping the landscape of biomedical research, offering the promise of accelerated timelines, reduced costs, improved success rates, and personalized medicine. The Artificial Intelligence in Drug Discovery Market is poised for massive growth, driven by technological advancements, increasing healthcare needs, and a booming pharmaceutical sector.
Introduction: The Convergence of AI and Life Sciences Traditionally, drug discovery is a time-consuming and costly process, often taking 10–15 years and billions of dollars to bring a single drug to market. Wi…
As I reflect on my time at SXSW 2025, I'm energised by the transformative ideas and conversations that dominated the healthcare marketing landscape, with authenticity and AI emerging as powerful forces driving change.
As I reflect on my time at SXSW 2025, I'm energised by the transformative ideas and conversations that dominated the healthcare marketing landscape, with authenticity and AI emerging as powerful forces driving change. The power of authentic messaging The most striking insight was how authenticity has become the cornerstone of effective healthcare communication. A panel featuring Eli Lilly highlighted the problematic lack of authentic representation of illness in the media. Viewers are increasingly demanding to see the full spectrum of health experiences - not just the sufferin…
On Sunday, the UK marked Mother’s Day, and my social feeds were packed with posts – flowers, handmade cards, perfectly plated meals, and, of course, a wave of ads pushing pricey gifts. The marketing wasn’t just from health and wellness brands, though “self-care” was a big theme. It was a full-on sales pitch from all corners, urging people to show appreciation in a way that often feels more commercial than meaningful.
On Sunday, the UK marked Mother’s Day, and my social feeds were packed with posts – flowers, handmade cards, perfectly plated meals, and, of course, a wave of ads pushing pricey gifts. The marketing wasn’t just from health and wellness brands, though “self-care” was a big theme. It was a full-on sales pitch from all corners, urging people to show appreciation in a way that ofte…
The global healthcare BPO services market is set to witness a growth rate of 9% in the next 5 years. Transition to ICD-10 coding standards and the forthcoming implementation of ICD-11; rising pressure to reduce healthcare costs; revenue losses caused by billing inaccuracies; increasing demand for specialized services; increasing complexity of healthcare operations; and limited in-house expertise; are some of the key factors driving the healthcare BPO services market.
The global healthcare BPO services market is set to witness a growth rate of 9% in the next 5 years. Transition to ICD-10 coding standards and the forthcoming implementation of ICD-11; rising pressure to reduce healthcare costs; revenue losses caused by billing inaccuracies; increasing demand for specialized services; incr…
The bioinformatics industry is poised for rapid growth due to several key factors. The rising demand for protein sequencing and nucleic acid research, combined with increased efforts from government and private organizations, is fueling the expansion of genomics and proteomics. Additionally, the surge in research on molecular genetics and drug development is further propelling the market. Significant investments in the biological sciences and information technology sectors are also contributing to the global bioinformatics market's growth.
Introduction The bioinformatics market is an essential segment of the biotechnology and healthcare industries, driven by advancements in data-driven research and technological innovations. As genomics, proteomics, and drug discovery expand, bioinformatics…
Selling medical devices to hospitals can be a lucrative yet challenging endeavor. With the healthcare industry growing and the demand for medical devices and medical equipment increasing, understanding how to sell medical devices effectively is crucial. In this guide, we’ll share key strategies for selling medical devices to hospitals, from identifying high-value facilities to proving your knowledge of their needs. Whether you’re selling medical equipment online or engaging with doctors and hospitals directly, these tips will help you navigate the complexities of the healthcare market.
  Selling medical devices to hospitals can be a lucrative yet challenging endeavor. With the healthcare industry growing and the demand for medical devices and medical equipment increasing, unde…
The medical equipment maintenance market is rapidly growing, driven by advanced technology, preventive maintenance, and increased healthcare spending. According to FutureWise analysis, the market was valued at US$ 48.8 billion in 2023 and is expected to reach US$ 111.01 billion by 2031, growing at a CAGR of 10.82%. Regular maintenance ensures patient safety, reduces downtime, and meets regulatory standards. Challenges include high costs, budget constraints, and environmental concerns. The future looks promising with AI-driven predictive maintenance and independent service providers. North America leads, while Asia-Pacific is the fastest-growing market.
Medical equipment plays a crucial role in hospitals and clinics. To ensure these devices work properly, regular maintenance is essential. Wi…
The PD-1 and PD-L1 inhibitors market is growing rapidly due to rising cancer cases and advancements in immunotherapy. These inhibitors help the immune system recognize and attack tumors by blocking immune checkpoints. Key drugs include Nivolumab, Pembrolizumab, and Atezolizumab. The market was valued at $41.83 billion in 2023 and is expected to reach $178.58 billion by 2032. Growth is driven by expanding treatment approvals, combination therapies, and regulatory support. Challenges include high costs and increasing competition. Recent innovations, like Ivonescimab outperforming Keytruda, highlight ongoing advancements in the field.
Introduction Programmed cell death protein 1 (PD-1) and its ligand, PD-L1, are crucial immune checkpoints that regulate the body's immune response. While they he…
Malignant Infantile Osteopetrosis (MIOP) is a rare genetic disorder causing excessive bone density, leading to brittle bones, bone marrow failure, and neurological issues. It results from mutations in genes like TCIRG1, CLCN7, and OSTM1, affecting bone resorption. Symptoms include fractures, anemia, infections, vision/hearing loss, and hepatosplenomegaly. Diagnosis involves X-rays, genetic testing, and blood tests. Hematopoietic Stem Cell Transplantation (HSCT) is the only curative treatment, with supportive therapies like vitamin D, corticosteroids, and erythropoietin. According to Futurewise, the MIOP market was US$ 159.02 million in 2024 and is expected to grow at a 7% CAGR by 2032.
Malignant Infantile Osteopetrosis (MIOP), also known as autosomal recessive osteopetrosis, is a rare g…
Discover the ultimate guide to becoming a medical sales rep. Learn about different sales roles, including medical devices, pharmaceuticals, and healthcare software. Understand key responsibilities, essential skills, and how to meet industry compliance requirements. Find out how to gain relevant experience through internships, training programs, and sales roles. Learn the differences between inbound and outbound sales, and get tips on preparing for interviews to stand out in a competitive field. Explore the benefits of training programs like Medical Sales College, Medical Sales 101, and New To Medical Device Sales. With potential earnings of $68,000 to over $100,000 per year, this lucrative career offers substantial growth. Start your journey to building strong relationships with healthcare professionals and succeeding in the medtech industry today.
Discover the latest AI innovations transforming healthcare in 2025. From enhanced diagnostics and personalized patient care to operational efficiency, artificial intelligence is reshaping the medical landscape. Learn about top companies like Cleerly, Qure.ai, Owkin, Vitazi.ai, and Exscientia leading the charge with AI-powered solutions. This comprehensive overview also addresses critical challenges like data privacy, algorithm bias, and regulatory compliance. Alpha Sophia supports sales teams by making it easier to find doctors and engage early adopters, helping accelerate AI adoption across the healthcare industry. Find out how AI is redefining healthcare and how Alpha Sophia can help you reach the right audience faster.
AI in Healthcare: Key Innovations and 5 Companies to Watch in 2025…
The global compounding pharmacy market, valued at US$ 13,474.6 million in 2023, is projected to grow at a CAGR of 6.5% from 2024 to 2034, reaching over US$ 26,838.8 million by the end of 2034. 
The global compounding pharmacy market, valued at US$ 13,474.6 million in 2023, is projected to grow at a CAGR of 6.5% from 2024 to 2034, reaching over US$ 26,838.8 million by the end of 2034.  This growth is driven by the increasing demand for personalized medications, advancements in pharmaceutical compounding techniques, and a rising prevalence of chronic diseases requiring tailored therapeutic solutions. The global compounding pharmacy market is experiencing significant growth, driven by the increasing demand for personalized medication solutions and the rising prevalence…
The Global Non-invasive Monitoring Device market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033
The Non-invasive Monitoring Device Market Research Report for 2025 delivers a comprehensive analysis of the industry's progress, examining both historical trends and the current market landscape. It provides key insights into production costs, market valuation, volume, and growth trajectories. The sector is undergoing major shifts, fuelled by innovative product categories like [Cardiac Monitoring Devices, Brain Monitoring Devices, Blood Pressure Monitoring Devices] and Game-changing applications such as [Online, Pet Stores & Retail Stores]. These changes are redefining industry standards and reshaping consumer expectations. With techn…
The Global Soliris (Eculizumab) market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033
The Soliris (Eculizumab) Market Research Report for 2025 delivers a comprehensive analysis of the industry's progress, examining both historical trends and the current market landscape. It provides key insights into production costs, market valuation, volume, and growth trajectories. The sector is undergoing major shifts, fuelled by innovative product categories like [Plasma Exchange, Plasma Infusion, Other] and Game-changing applications such as [PNH, aHUS, Others]. These changes are redefining industry standards and reshaping consumer expectations. With technology advancing rapidly, these transformations are poised to ignite a new era of growth a…
Anemia is a serious medical condition affecting millions of people worldwide, characterized by a lack of healthy red blood cells to carry adequate oxygen to the body's tissues. This condition can lead to fatigue, weakness, and various health complications if left untreated. According to the World Health Organization, anemia affects approximately 1.62 billion people globally, with iron deficiency being the most common cause.
Anemia is a serious medical condition affecting millions of people worldwide, characterized by a lack of healthy red blood cells to carry adequate oxygen to the body's tissues. This condition can lead to fatigue, weakness, and various health complications if left untreated. According to the World Health Organization, anemia affects approximately 1.62 billion people globa…
Digital Pathology refers to the digitization of pathology processes. It involves acquiring, managing, sharing, and interpreting pathological information derived from digitized specimen slides.
According to FutureWise analysis the market for Artificial Intelligence in Digital Pathology in 2023 is US$ 0.33 billion, and is expected to reach US$ 1.17 billion by 2031 at a CAGR of 17%. Digital Pathology refers to the digitization of pathology processes. It involves the acquisition, management, sharing, and interpretation of pathological information derived from digitized specimen slides. This field utilizes Whole Slide Imaging (WSI), also known as Virtual Microscopy, which converts traditional microscopic slides into digital images for easier analysis, management, and sharing via Whole…